ArticleFrontiers in genetics2026
Fetal Y chromosome abnormalities cause false-low fetal fraction in NIPT: a retrospective analysis of 24,101 pregnant women.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low fetal fraction is a common cause of NIPT no-call results, leading to repeat sampling and delayed clinical decisions. In cases of fetal sex chromosome abnormalities (SCAs), the standard Y chromosome-based method for estimating fetal fraction (FF) may be unreliable, potentially leading to misinterpretation of low-FF results. Methods: We retrospectively analyzed 24,101 pregnant women who underwent NIPT between January 2023 and January 2025. FF was estimated using the Y chromosome-based method for male fetuses and FF-QuantSC for female fetuses. Confirmatory invasive testing was performed for high-risk or failed cases. Results: The SCA prevalence was significantly higher in the low-FF group (FF<3.5%, n = 70) than in the adequate-FF group (FF ≥ 3.5%, n = 24,020), representing a ∼78-fold increased risk (11.43% versus 0.21%; OR = 78.227, Conclusion: Low FF in NIPT is strongly associated with fetal Y-chromosome abnormalities, suggesting that Y chromosome-based FF estimation may produce a "false-low" FF in some cases with fetal Y-chromosome abnormalities. We suggest that re-estimating FF using FF-QuantSC combined with Y-chromosome read distribution analysis may be considered before reporting test failure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.